CI

At a glance

ClinicalIndex Comparison Record
Phase 1Recruiting· 30 target
Drug / intervention
JMKX000197 +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06740019
NCT06740019Phase 1RecruitingUpdate OverdueUpdated 14mo ago · Completion was 6mo ago
Enrollment Stalled
Update Overdue
CompareCT.gov

A Phase Ib, Open Label, Multicenter Clinical Study to Evaluate the Safety, Tolerance, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of JMKX000197 Injection in the Treatment of Malignant Pleural Effusion

Jemincare·interventional·Posted Dec 18, 2024·Updated Apr 4, 2025

In Brief

A Phase 1 clinical trial evaluating JMKX000197 and Tube thoracostomy drainage for Malignant Pleural Effusions (Mpe). Currently recruiting, targeting 30 participants across 1 site.

Signals

Enrollment appears stalled

Detailed Summary

A Phase Ib Study to Evaluate the Safety, Tolerance, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of JMKX000197 Injection in the Treatment of Malignant Pleural Effusion

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMalignant Pleural Effusions (Mpe)
CountriesChina
Collaborators--

Timeline

Phase 1Recruiting
20252026
First PostedDec 18, 2024
Enrollment StartDec 28, 2024
Primary CompletionDec 31, 2025
Study CompletionNov 1, 2026
TodayJul 1, 2026
Enrollment to primary: 1.0 yearsPosted 1.5 years ago

Interventions

JMKX000197drug

for pleural perfusion

Tube thoracostomy drainageprocedure

Tube thoracostomy drainage